BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26538717)

  • 1. Clinico-epidemiological Study and Quality of Life Assessment in Melasma.
    Yalamanchili R; Shastry V; Betkerur J
    Indian J Dermatol; 2015; 60(5):519. PubMed ID: 26538717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.
    Cestari TF; Hexsel D; Viegas ML; Azulay L; Hassun K; Almeida AR; RĂªgo VR; Mendes AM; Filho JW; Junqueira H
    Br J Dermatol; 2006 Dec; 156 Suppl 1():13-20. PubMed ID: 17176300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is There a Correlation between Severity of Melasma and Quality of Life?
    Jusuf NK; Putra IB; Mahdalena M
    Open Access Maced J Med Sci; 2019 Aug; 7(16):2615-2618. PubMed ID: 31777617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the quality of life among melasma patients using the MELASQoL scale: A systematic review and meta-analysis.
    Zhu Y; Zeng X; Ying J; Cai Y; Qiu Y; Xiang W
    PLoS One; 2022; 17(1):e0262833. PubMed ID: 35085327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of melasma on quality of life in a sample of women living in southern Brazil.
    Freitag FM; Cestari TF; Leopoldo LR; Paludo P; Boza JC
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):655-62. PubMed ID: 18410339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dermoscopic characteristics of melasma in relation to different skin phototypes, distribution patterns and wood lamp findings: a cross-sectional study of 236 melasma lesions.
    Bostan E; Cakir A
    Arch Dermatol Res; 2023 Sep; 315(7):1927-1938. PubMed ID: 36853510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a melasma quality of life questionnaire for the Turkish language: the MelasQoL-TR study.
    Dogramaci AC; Havlucu DY; Inandi T; Balkrishnan R
    J Dermatolog Treat; 2009; 20(2):95-9. PubMed ID: 18720186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melasma in Latina patients: cross-cultural adaptation and validation of a quality-of-life questionnaire in Spanish language.
    Dominguez AR; Balkrishnan R; Ellzey AR; Pandya AG
    J Am Acad Dermatol; 2006 Jul; 55(1):59-66. PubMed ID: 16781293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Melasma on the Quality of Life in People with Darker Skin Types Living in Durban, South Africa.
    Mpofana N; Paulse M; Gqaleni N; Makgobole MU; Pillay P; Hussein A; Dlova NC
    Int J Environ Res Public Health; 2023 Nov; 20(22):. PubMed ID: 37998299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Efficacy and Safety on Combining 20% Trichloroacetic Acid Peel with Topical 5% Ascorbic Acid for Melasma.
    Dayal S; Sahu P; Yadav M; Jain VK
    J Clin Diagn Res; 2017 Sep; 11(9):WC08-WC11. PubMed ID: 29207818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermoscopic evaluation of tranexamic acid versus Vitamin C, with microneedling in the treatment of melasma: a comparative, split-face, single-blinded study.
    Tahoun AI; Mostafa WZ; Amer MA
    J Dermatolog Treat; 2022 May; 33(3):1623-1629. PubMed ID: 33393842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with quality of life in facial melasma: a cross-sectional study.
    Pollo CF; Miot LDB; Meneguin S; Miot HA
    Int J Cosmet Sci; 2018 May; ():. PubMed ID: 29734511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional, multicentric clinico-epidemiological study of melasma in India.
    KrupaShankar DS; Somani VK; Kohli M; Sharad J; Ganjoo A; Kandhari S; Mysore VR; Aurangabadkar S; Malakar S; Vedamurthy M; Kadhe G; Motlekar S; Ahirrao P
    Dermatol Ther (Heidelb); 2014 Jun; 4(1):71-81. PubMed ID: 24643868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinico-epidemiological study of different dermoscopic patterns in hyperpigmented facial lesions in a tertiary care centre.
    Solanki V; Dongre A; Nayak C
    J Cutan Aesthet Surg; 2024; 17(2):112-123. PubMed ID: 38800811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a health-related quality of life instrument for women with melasma.
    Balkrishnan R; McMichael AJ; Camacho FT; Saltzberg F; Housman TS; Grummer S; Feldman SR; Chren MM
    Br J Dermatol; 2003 Sep; 149(3):572-7. PubMed ID: 14510991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Dermoscopic Features in Facial Melanosis with Wood Lamp Examination.
    Amatya B
    Dermatol Pract Concept; 2022 Feb; 12(1):e2022030. PubMed ID: 35223174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microneedling with glutathione versus microneedling alone in treatment of facial melasma: Split-face comparative study.
    Mohamed M; Beshay YMA; Assaf HM
    J Cosmet Dermatol; 2023 Dec; 22(12):3379-3386. PubMed ID: 37313658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a Hindi language health-related quality of life questionnaire for melasma in Indian patients.
    Sarkar R; Garg S; Dominguez A; Balkrishnan R; Jain RK; Pandya AG
    Indian J Dermatol Venereol Leprol; 2016; 82(1):16-22. PubMed ID: 26728805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels.
    Sharquie KE; Al-Tikreety MM; Al-Mashhadani SA
    Dermatol Surg; 2006 Dec; 32(12):1429-36. PubMed ID: 17199649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study.
    Sanchez NP; Pathak MA; Sato S; Fitzpatrick TB; Sanchez JL; Mihm MC
    J Am Acad Dermatol; 1981 Jun; 4(6):698-710. PubMed ID: 6787100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.